Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. AMENDED AND RESTATED LICENSE AGREEMENT dated August 6, 2012 by and between ALFA WASSERMANN S.P.A. and SALIX PHARMACEUTICALS, INC.License Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) dated August 6, 2012 (the “Amendment Effective Date”) by and between Alfa Wassermann S.p.A., a corporation incorporated under the laws of Italy (“Alfa”), and Salix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of California, United States of America (“Salix”) (each, a “Party” and, collectively, the “Parties”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. AMENDMENT NUMBER TWO TO SUPPLY AGREEMENTSupply Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
This Amendment Number Two to Supply Agreement (this “Amendment”), dated August 6, 2012 (the “Amendment Number Two Effective Date”), is made by and between Alfa Wassermann S.p.A., an Italian company (“Alfa”), and Salix Pharmaceuticals, Inc., a California corporation (“Salix”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. EIR SUPPLY AGREEMENT dated August 6, 2012 by and between ALFA WASSERMANN S.P.A. and SALIX PHARMACEUTICALS, INC.Supply Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
EIR SUPPLY AGREEMENT (this “Agreement”) dated August 6, 2012 (the “Effective Date”) by and between Alfa Wassermann S.p.A., a corporation incorporated under the laws of Italy (“Alfa”), and Salix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of California, United States of America (“Salix”) (each, a “Party” and, collectively, the “Parties”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. TRADEMARK LICENSE AGREEMENT (ALFA TO SALIX) dated August 6, 2012 by and between ALFA WASSERMANN HUNGARY KFT. and SALIX PHARMACEUTICALS, INC.Trademark License Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
TRADEMARK LICENSE AGREEMENT (this “Agreement”) dated August 6, 2012 by and among Alfa Wassermann Hungary Kft., a corporation organized under the laws of Hungary (“AWH”), and Salix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of California, United States of America (“Salix”) (each, a “Party” and, collectively, the “Parties”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. Salix Pharmaceuticals, Inc.License Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
We refer to Section 11.7.2(b) of that certain Amended and Restated License Agreement, dated 6 August 2012, between us. The reference to “Alfa” contained in clause (ii) of the first sentence of the said section was in error and is hereby deleted and replaced by a reference to “Salix.”
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. TRADEMARK LICENSE AGREEMENT (SALIX TO ALFA) dated August 6, 2012 by and between ALFA WASSERMANN S.P.A. and SALIX PHARMACEUTICALS, INC.Trademark License Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
TRADEMARK LICENSE AGREEMENT (this “Agreement”) dated August 6, 2012 by and among Alfa Wassermann S.p.A., a corporation organized under the laws of Italy (“Alfa”), and Salix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of California, United States of America (“Salix”) (each, a “Party” and, collectively, the “Parties”).
